Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21

被引：10
作者：
Chervenak, FA
McCullough, LB
Chasen, ST
机构：
[1] Cornell Univ, Dept Obstet & Gynecol, Weill Med Coll, New York, NY 10021 USA
[2] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA
来源：
SEMINARS IN PERINATOLOGY | 2005年 / 29卷 / 04期
关键词：
informed consent; ethics; trisomy; 21; risk assessment; first trimester; nuchal translucency;
D O I：
10.1053/j.semperi.2005.05.012
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 22 条
[1]   Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? [J].
Chasen, ST ;
McCullough, LB ;
Chervenak, FA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (03) :769-774
[2]  
Chasen ST, 2002, J ULTRAS MED, V21, P483
[3]  
Chasen ST, 2001, J ULTRAS MED, V20, P1147
[4]   PRENATAL INFORMED CONSENT FOR SONOGRAM - AN INDICATION FOR OBSTETRIC ULTRASONOGRAPHY [J].
CHERVENAK, FA ;
MCCULLOUGH, LB ;
CHERVENAK, JL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (04) :857-860
[5]  
FADEN RR, 1986, HIST THEORY INFORMED
[6]   Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome [J].
Hackshaw, AK ;
Wald, NJ .
PRENATAL DIAGNOSIS, 2001, 21 (09) :737-740
[7]  
Kornman LH, 1997, PRENATAL DIAG, V17, P1011, DOI 10.1002/(SICI)1097-0223(199711)17:11<1011::AID-PD193>3.0.CO
[8]  
2-1
[9]  
McCullough LB., 1998, J GREGORY INVENTION, DOI DOI 10.1136/JME-2022-108735
[10]  
MCULLOUGH LB, 1994, ETHICS OBSTET GYNECO
123